DUENDA Trademark

Trademark Overview

On Monday, June 1, 2015, a trademark application was filed for DUENDA with the United States Patent and Trademark Office. The USPTO has given the DUENDA trademark a serial number of 86647477. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 4, 2019. This trademark is owned by Glaxo Group Limited. The DUENDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
duenda

General Information

Serial Number86647477
Word MarkDUENDA
Filing DateMonday, June 1, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 4, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 1, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe English translation of the word "DUENDA" in the mark is "tame", "gentle", "domestic".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 8, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, March 4, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 4, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, July 6, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 5, 2018EXTENSION 5 GRANTED
Monday, July 2, 2018EXTENSION 5 FILED
Monday, July 2, 2018TEAS EXTENSION RECEIVED
Thursday, November 16, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 14, 2017EXTENSION 4 GRANTED
Tuesday, November 14, 2017EXTENSION 4 FILED
Tuesday, November 14, 2017TEAS EXTENSION RECEIVED
Thursday, July 13, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 11, 2017EXTENSION 3 GRANTED
Tuesday, July 11, 2017EXTENSION 3 FILED
Tuesday, July 11, 2017TEAS EXTENSION RECEIVED
Friday, December 30, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 29, 2016EXTENSION 2 GRANTED
Tuesday, December 6, 2016EXTENSION 2 FILED
Saturday, December 24, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 6, 2016TEAS EXTENSION RECEIVED
Thursday, July 28, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 26, 2016EXTENSION 1 GRANTED
Tuesday, July 26, 2016EXTENSION 1 FILED
Tuesday, July 26, 2016TEAS EXTENSION RECEIVED
Tuesday, January 26, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 1, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 1, 2015PUBLISHED FOR OPPOSITION
Wednesday, November 11, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 27, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 22, 2015ASSIGNED TO LIE
Friday, September 18, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 18, 2015EXAMINER'S AMENDMENT ENTERED
Friday, September 18, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, September 18, 2015EXAMINERS AMENDMENT E-MAILED
Friday, September 18, 2015EXAMINERS AMENDMENT -WRITTEN
Friday, September 11, 2015ASSIGNED TO EXAMINER
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 8, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 4, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

duenda pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological